# A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients

> **NCT00002435** · PHASE2 · COMPLETED · sponsor: **Pharmacia**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Thymic Humoral Factor
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00002435
- **Lead sponsor:** Pharmacia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002435, "A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*